Previous studies have shown that members of the steroid receptor family of transcriptional regulators can function synergistically when bound to multiple arrays of specific DNA binding sites known as hormone response elements, usually located upstream of target genes. We have constructed a mammalian expression vector containing a synthetic promoter composed of five high-affinity glucocorticoid response elements (termed GRE5) placed upstream of the adenovirus 2 major late promoter "TATA" region. In transiently transfected HeLa cells in the presence of dexamethasone, the GRE5 promoter was at least 50-fold more efficient than the mouse mammary tumor virus long terminal repeat in expressing bacterial chloramphenicol acetyltransferase activity. When the GRE5 vector was introduced stably into the HeLa cell genome, chloramphenicol acetyltransferase activity was induced from 10-to >50-fold by dexamethasone in six of eight responsive clones. C (16, 20, 21) containing a 66-to 68-aa core composed of two zinc fingers (22) (23) (24) , which is essential for recognition of REs. Three amino acids adjacent to the N-terminal zinc finger of the DNA binding domain, known as the P-box, are critical for DNA sequence recognition (25) (26) (27) . A subfamily composed of the glucocorticoid, mineralocorticoid, progesterone, and androgen receptors contain Gly, Ser, and Val at discriminatory positions of the P-box and recognize AGAACA half-sites arranged in a palindrome with a 3-bp spacer region (25) (26) (27) . The ligand-binding domain, located C-terminal to the DNA binding domain in region E, is less well conserved among the receptors and contains a ligand-inducible transcriptional-activation function (7-10, 17, 18). Transcriptional-activating domains have also been identified in the poorly conserved N-terminal A/B regions of the glucocorticoid and estrogen receptors (17, 18, 28) .
constructed a mammalian expression vector containing a synthetic promoter composed of five high-affinity glucocorticoid response elements (termed GRE5) placed upstream of the adenovirus 2 major late promoter "TATA" region. In transiently transfected HeLa cells in the presence of dexamethasone, the GRE5 promoter was at least 50-fold more efficient than the mouse mammary tumor virus long terminal repeat in expressing bacterial chloramphenicol acetyltransferase activity. When the GRE5 vector was introduced stably into the HeLa cell genome, chloramphenicol acetyltransferase activity was induced from 10-to >50-fold by dexamethasone in six of eight responsive clones. The levels of both basal and induced expression varied from one clone to the next, probably due to an effect of chromosomal location on promoter activity. When propagated stably in HeLa cells in an Epstein-Barr virus episomal vector, the GRE5 promoter was >50-fold inducible and its activity was strictly dependent on the presence of dexamethasone. We also show that the GRE5 promoter stably propagated in HeLa cells is inducible by progesterone in the presence of a transiently transfected progesterone receptor expression vector. The GRE5 promoter should be widely applicable for the strictly controlled high-level expression of target genes in eukaryotic cells that contain either the glucocorticoid or progesterone receptors.
Transcription of eukaryotic class II genes is regulated by a complex array of trans-acting transcription factors that bind to specific DNA sequences in the promoter of a target gene. On most promoters transcriptional preinitiation complexes are assembled at the "TATA" box that is located 25-30 bp 5' to the site of initiation (1) . Preinitiation complex assembly is regulated by factors that bind to DNA sequences known as enhancers often situated at various distances upstream of the TATA box/initiation site (2) (3) (4) . Enhancers can be located immediately adjacent to the site oftranscriptional initiation or several kilobases distant from it (5, 6) . The activity of enhancer factors can be directly responsive to specific intercellular signals or indirectly via intracellular transduction pathways (7) (8) (9) (10) (11) (12) (13) (14) (15) .
The nuclear receptors represent a family of transcriptional enhancer factors that act by binding to specific DNA sequences found in target promoters known as response elements (REs) (7) (8) (9) (10) . Specific members ofthe nuclear receptor family represent the primary intracellular targets for small lipid-soluble ligands (such as steroid and thyroid hormones, retinoids, and vitamin D3) and as such act as ligand-inducible
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. transcription factors. Sequence comparisons (16) and structure-function analyses (17) (18) (19) (20) have shown that the receptors are composed of a series of conserved domains. The most highly conserved domain is the DNA binding domain located in region C (16, 20, 21) containing a 66-to 68-aa core composed of two zinc fingers (22) (23) (24) , which is essential for recognition of REs. Three amino acids adjacent to the N-terminal zinc finger of the DNA binding domain, known as the P-box, are critical for DNA sequence recognition (25) (26) (27) . A subfamily composed of the glucocorticoid, mineralocorticoid, progesterone, and androgen receptors contain Gly, Ser, and Val at discriminatory positions of the P-box and recognize AGAACA half-sites arranged in a palindrome with a 3-bp spacer region (25) (26) (27) . The ligand-binding domain, located C-terminal to the DNA binding domain in region E, is less well conserved among the receptors and contains a ligand-inducible transcriptional-activation function (7-10, 17, 18) . Transcriptional-activating domains have also been identified in the poorly conserved N-terminal A/B regions of the glucocorticoid and estrogen receptors (17, 18, 28) .
REs are often found in multiple arrays, usually located upstream ofthe site of transcriptional initiation (6, 29, 30) and many studies have shown that REs can act synergistically to regulate transcription. Functional analysis of two glucocorticoid response elements (GREs) located far upstream of the rat tyrosine aminotransferase (TAT) gene has shown that they combine synergistically to mediate transcriptional activation by the glucocorticoid receptor (GR) (6) . The two nonconsensus estrogen response elements (EREs) of the Xenopus vitellogenin Bi gene are virtually inactive in isolation but together mediate estrogen-dependent transcriptional activation in transiently transfected cells (29) . The degree of synergism between paired EREs or GREs is dependent on their sequence, the spacing between them, and their distance from the TATA box of the promoter (31, 32, 49) . Several studies have also shown that nuclear receptors and other classes of transcriptional regulators can combine to activate transcription synergistically (28, 32) .
Promoters activated by specific inducible nuclear receptors are well suited for eukaryotic expression vectors since expression of genes can be regulated simply by controlling the concentration of ligand present in the growth medium (18, (33) (34) (35) . Glucocorticoid-inducible promoters such as that of the long terminal repeat of the mouse mammary tumor virus (MMTV) have been widely used in this regard because the GR is expressed in a wide variety of cell types. The MMTV GRE is composed largely of a series of half-sites (36, 37 
MATERIALS AND METHODS
Recombinant Plasmids. A 35-bp oligonucleotide containing the rat TAT GRE flanked by BamHI and Bgl II ends was concatemerized in the presence of BamHI, Bgl II, and T4 DNA ligase, and bands corresponding to dimers and pentamers were purified from a 5% polyacrylamide gel for insertion into the Bgl II site (position -65) of pAL10 (31) . Recombinants containing a single GRE or head-to-tail direct repeats of GREs conserving the Bgl II site at position -65 were isolated to create GRE/pAL10, GRE2/pAL10, and GRE5/pAL10. GRE5/pAL10 was then modified to remove unnecessary sequence and restriction sites, and a polylinker containing sites for EcoRI, Kpn I, Sma I, Sac I, Xho I, HindIII, and Bgl II was inserted in either orientation to create pGRE5-1 and pGRE5-2 (see Fig. 2 ). The rabbit f3-globin sequence ofpGRE5 runs from the naturally occurring BamHI site to the EcoRI site and contains the second globin intron (39) . To create pGRE5/CAT recombinants, the Bgl II-Sma I fragment from pBLCAT8+ (40) containing the CAT gene was excised and inserted in the pGRE5-1 or pGRE5-2 polylinker digested with Sma I and Bgl II in the sense and antisense orientations, respectively. The pGREltkCAT and pGRE2tkCAT plasmids were created by inserting one or two perfectly palindromic GREs upstream of the herpes simplex virus thymidine kinase (tk) promoter in pBLCAT8+. To create p220.2-GRE5/CAT recombinants, the Xba I-Sal I fragment (see Fig. 2 ) from pGRE5/CAT was inserted in the EBV episomal vector p220.2 (41, 42) (Fig. 1, lanes 1-3, 5, 7, and 9 ). The recombinant GREl containing a single GRE upstream of the Ad2MLP TATA region did not produce detectable transcription in the presence of dexamethasone (Fig. 1, lane 4) . In contrast, dexamethasone-inducible transcription was observed from the Ad2MLP in recombinants containing two or more GREs (Fig.  1, lanes 5-10) . Promoters containing five GREs were 8-fold more inducible than those containing only two elements (Fig.  1, compare lanes 6 and 8) , consistent with previous observations that multiple REs can act synergistically to mediate ligand-dependent transcriptional activation by nuclear receptors (6, (29) (30) (31) . The promoter of the GRE5 recombinant was also >3-fold more efficient in the presence of dexamethasone than the constitutively active promoter of an Ad2MLP recombinant containing an equivalently positioned simian virus 40 (SV40) enhancer (Fig. 1, lanes 7-10) .
The above results show that introduction of five GREs upstream of the Ad2MLP TATA region creates a promoter that has very low basal activity and is highly inducible in HeLa cells by the endogenous levels of ligand-activated GR. We have therefore constructed two eukaryotic expression vectors based on this promoter, pGRE5-1 and pGRE5-2, containing polylinker sequences in opposite orientations ( Fig. 2A) . The polylinker of each vector was inserted between a fragment of rabbit ,,-globin gene sequence that contains an intron and a sequence from the SV40 genome containing a poly(A) addition signal. To test the capacity of these vectors to induce expression of high levels of protein, we inserted the bacterial CAT gene into pGRE5-2 and introduced the recombinant plasmid into HeLa cells by transient transfection. dexamethasone-inducible CAT expression vectors containing synthetic promoters and to MMTV/CAT, by using quantities of extract normalized to the activity of the 3-galactosidase internal control (Fig. 2B) . No induction of CAT activity by dexamethasone was observed in extracts of cells transfected with pBLCAT8+, which contains the herpes simplex virus tk promoter but no GREs (Fig. 2B, lanes 11 and 12) . Insertion of one or two GREs upstream of the tk promoter gave rise to dexamethasone-inducible CAT activity (Fig. 2B, lanes 5-8) . The induced activity of the GRE2tk promoter was 3-fold higher than that observed with the GREltk promoter. Strikingly, transfection ofeither oftwo independent preparations of GRE5-2/CAT into HeLa cells in the presence of dexamethasone gave rise to >10-and 30-fold more CAT activity than observed with GRE2tkCAT and GREltkCAT, respectively (Fig. 2B, lanes 2 and 4) . No induction ofactivity was observed when the CAT gene was inserted in pGRE5-1 in the antisense orientation (data not shown). Virtually no dexamethasoneinducible CAT activity was observed in extracts of cells transfected with MMTV/CAT (Fig. 2B, lanes 9 and 10) . However, activity was clearly observed if25-fold more extract was used (Fig. 2B, lanes 13 and 14) . Under these conditions, the activity of pGRE5-2/CAT in the presence of dexamethasone was at least 50-fold higher than that of the MMTV/CAT. Moreover, whereas the inducible activity of the MMTV promoter was enhanced >5-fold by cotransfection of a GR expression vector, the activity of the GRE5 promoter was not significantly affected (data not shown), indicating that the GRE5 promoter is efficiently inducible by endogenous levels of GR in HeLa cells. We have also compared the activity in HeLa cells ofpGRE5-2/CAT to the constitutively active SV40 and cytomegalovirus (CMV) enhancer-based promoters of pSV2-CAT and CMV-CAT and observed that, in the presence of dexamethasone, the pGRE5 promoter was much more efficient than either the pSV2 or pCMV promoters (Fig. 2C) . Under these conditions the CMV promoter was as efficient as the induced MMTV promoter (data not shown). These results demonstrate that high levels of induction by dexamethasone can be obtained when using a promoter composed solely of multiple GREs and a TATA region.
The pGRE5 Promoter Is Functional in Stably Transfected Cells. Since the pGRE5 vectors contain a synthetic promoter, it is important to verify that they are functional when stably propagated in cells. The pGRE5/CAT plasmid was, therefore, introduced into HeLa cells by cotransfection with the pRcRSV vector, which expresses the neomycin-resistance gene. Of 22 neomycin-resistant clones, 8 expressed CAT activity. These 8 clones displayed variable levels of background activity and dexamethasone inducibility (Fig. 3A) . The quantities of extract tested correspond to 0.4% (1 ,ul) and 4% (10 ul) of the total extract from 9-cm plates of cells harvested at 70% confluency (-2.5 ,ug and -25 pg of protein, respectively). Six clones (17-4, 18-5, 18-7, 18-8, 19-11 , and 20-5) showed a combination of little background activity and high levels of induction in the presence of dexamethasone (Fig. 3A, lanes 5-12, 21-24, and 29-32) . Indeed, no CAT activity was visible with extracts of the clone 19-11 not treated with dexamethasone under these conditions (Fig. 3,  lanes 21 and 23) . We have also found (Fig. 3B ) that the GRE5 promoter was strongly inducible by dexamethasone when propagated in the EBV episomal vector p220.2 (41, 42) . No CAT activity was observed in extracts of cells transfected with p220.2-GRE5-1/CAT, which carries the CAT gene in the antisense orientation (Fig. 3B, lanes 1 and 2) . In contrast, very low background activity and high dexamethasone inducibility were observed in extracts of cells transfected with p220.2-GRE5-2/CAT, which expresses the CAT gene (Fig.  3B, lanes 3-10) . These results are typical of other clones tested (data not shown). The levels of activity observed in [21] [22] [23] [24] was treated with 100 nM progesterone (lanes 2 and 4) for 48 hr prior to harvesting. Extracts used in lanes 3 and 4 were made from cells transfected with 1 ug of the human progesterone expression vector hPRO (43) whereas those used in lanes 1 and 2 were made from untransfected cells.
clones 6 and 7 were comparable to that observed with G418-resistant HeLa clone 19-11 (Fig. 3A, lanes 21-24) .
Induction of the GRE5 Vector by Progesterone in Stably Transfected Cells. The TAT GRE can confer responsiveness to both glucocorticoids and progesterone in transiently transfected cells when placed upstream of an unresponsive promoter (46) , and the progesterone receptor binds to the element in vitro (46) . We used the HeLa cell line (Fig.  3A) to determine whether the GRE5 promoter was progesterone-responsive in stably transfected cells. No CAT activity was observed in 19-11 cells treated or not with progesterone (Fig. 3C, lanes 1 and 2) . However, upon transient transfection with the human progesterone receptor expression vector hPRO, progesterone-responsive CAT activity was observed (Fig. 3C, lanes 3 and 4) . These results demonstrate that the GRE5 promoter is progesterone-responsive in the presence of the progesterone receptor when stably integrated in the HeLa cell genome. DISCUSSION Previous experiments (31) with the estrogen receptor have demonstrated that a minimal promoter composed of one or more EREs and a TATA region is estrogen-inducible in transiently transfected cells. Several studies have shown that multiple hormone REs can act synergistically to mediate a transcriptional response to steroid hormones (6, (29) (30) (31) . We have constructed here a dexamethasone-inducible minimal promoter composed of five high-affinity rat TAT GREs placed upstream of the Ad2MLP TATA region. Experiments in transiently transfected HeLa cells indicated that the five REs act synergistically. The GRE5 promoter is highly inducible by dexamethasone whereas analogous promoters containing one or two REs are not or are only weakly responsive to hormone (Figs. 1 and 2 ). The GRE5 promoter is at least 50-fold more inducible by dexamethasone than the MMTV promoter in transiently transfected HeLa cells (Fig. 2) , and at least 3-fold stronger than the constitutive activity of an analogous promoter containing an equivalently positioned SV40 enhancer (Fig. 1) . The GRE5 promoter is also 23- (Fig. 3) , indicating that under these conditions GREs and a TATA region are sufficient for an efficient response to hormone. Variable levels of dexamethasoneindependent CAT activity are observed in HeLa cell clones carrying the GRE5/CAT recombinant incorporated into the genome (Fig. 3) . The degree ofhormone-independent activity is probably dependent on the proximity of the promoter to constitutively active enhancers that activate transcription from the Ad2MLP or its insertion downstream from dexamethasone-independent promoters. Based on these results, it is difficult to determine the basal activity of the GRE5 promoter in a transcriptionally silent chromosomal background. To control the transcriptional environment as much as possible the GRE5 promoter was inserted in the EBV Proc. Natl. Acad Sci. USA 90 (1993) episomal vector p220.2 (41, 42) , which replicates autonomously in human cells. Under these conditions, the promoter is highly inducible, and very low levels of CAT activity are detected only with large amounts of extracts of cells cultured in the absence of dexamethasone (Fig. 3 and data not shown) . GRE5 promoter activity in the EBV vector resembles closely that of the HeLa cell clone (Fig. 3) , created by the cotransfection of pGRE5/CAT and a vector expressing neomycin resistance, suggesting that the basal activity of GRE5 in clone 19-11 is not influenced by nearby promoters or enhancer elements. Thus these results indicate that, when propagated stably in a controlled transcriptional environment, GRES promoter activity is highly inducible and is strictly dependent on the presence of inducer. We also note that the high levels of induction observed raise the possibility that the GRE5 promoter/expression system can be used as a straightforward method for the controlled overproduction of proteins for purification and physical characterization.
Recent studies with the steroid-inducible MMTV promoter have suggested that chromatin structure may control the access of nuclear receptors to REs (38) . While the MMTV promoter is responsive to progesterone and glucocorticoids in transiently transfected cells (47) , it is inducible by glucocorticoids but not progesterone when stably propagated in an episomal vector (38, 48) . Our results show that the GRE5 promoter is inducible by progesterone in the HeLa 19-11 clone transiently transfected with the human progesterone receptor expression vector hPRO (Fig. 3C) . These results indicate that the GRE5 promoter can be activated by progesterone and glucocorticoids thus extending the range ofcell types where the expression system is functional. It is also possible that ligand-activated receptors for mineralocorticoids and androgens can activate the GRE5 promoter given that these receptors recognize GREs.
In summary, we have developed a fully defined synthetic steroid-inducible promoter-expression system that should be widely applicable for the tightly controlled expression of cloned genes in a wide variety of cell types expressing GRs or progesterone receptors and possibly in cells expressing androgen or mineralocorticoid receptors.
